Company: SNWV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023881
Chunk: 36

Company: SANUWAVE Health, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 36
---
 at March 31, 2025(in thousands)Fair value atMarch 31, 2025Quoted prices inactive markets(Level 1)Significant otherobservable inputs(Level 2)Significantunobservable inputs(Level 3)Warrant liability$13,008 $- $- $13,008 

14

Fair value measured at December 31, 2024(in thousands) Fair value at December 31, 2024Quoted prices inactive markets(Level 1)Significant otherobservable inputs(Level 2)Significant unobservable inputs(Level 3)Warrant liability$8,107 $- $- $8,107 There were no transfers among Levels 1, 2 or 3 during the three months ended March 31, 2025, and 2024. Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with liabilities within the Level 3 category include changes in fair value that were attributable to both observable and unobservable inputs.Warrant LiabilityThe Company's liability classified warrants as of March 31, 2025, and December 31, 2024, were valued using the Black Scholes valuation model.Significant Black Scholes valuation model inputs related to the Company’s warrants are listed below:March 31, 2025December 31, 2024Weighted average expected life in years0.610.85Weighted average volatility80%91%Value of underlying shares$35.37$22.76Weighted average risk free interest rate4.11%4.10%Expected dividend yield0%0%A summary of the Level 3 warrant activity for the three months ended March 31, 2025, is as follows:(in thousands, except per share data)WarrantsOutstanding Fair Valueper ShareWarrant LiabilityFair ValueBalance at December 31, 2024390$20.79 $8,107 Change in fair value-4,901 Balance at March 31, 2025390$33.35 $13,008 

11.        Promissory Notes Payable

Convertible Notes Payable and Convertible Notes Payable, Related Parties - In August 2022, November 2022, May 2023, December 2023, January 2024, and June 2024, the Company entered into Securities Purchase Agreements